Susquehanna International Group
MTCR

Susquehanna International Group’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Susquehanna International Group’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,500
Closed -$6K – 14591
2022
Q2 		$6K Buy
+11,500
New +$5.57K ﹤0.01% 12598

Other funds holding MTCR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Susquehanna International Group's MTCR Position: Q1 2023 in Review

Susquehanna International Group sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 24,060 shares — an estimated $10.8K sold.

Susquehanna International Group first reported a position in MTCR in Q4 2020 and held it in 7 quarters. The position peaked at $254K in Q4 2020. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

  • Susquehanna International Group reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 24,060 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $10.8K.
  • Susquehanna International Group first reported a position in Metacrine, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Susquehanna International Group's Metacrine, Inc. Common Stock position peaked at $254K in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.